Humana Inc. $HUM Position Lifted by Redwood Grove Capital LLC

Redwood Grove Capital LLC increased its stake in Humana Inc. (NYSE:HUM) by 8.7% during the first quarter, Holdings Channel.com reports. The firm owned 114,870 shares of the insurance provider’s stock after purchasing an additional 9,200 shares during the quarter. Humana accounts for approximately 6.4% of Redwood Grove Capital LLC’s holdings, making the stock its 4th largest position. Redwood Grove Capital LLC’s holdings in Humana were worth $19,917,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of HUM. Montag A & Associates Inc. increased its position in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its position in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new position in shares of Humana during the 4th quarter valued at approximately $27,000. Reflection Asset Management bought a new position in shares of Humana during the 4th quarter valued at approximately $29,000. Finally, Global Assets Advisory LLC purchased a new stake in Humana in the 1st quarter worth approximately $38,000. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Wolfe Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Leerink Partners increased their price objective on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research note on Thursday, April 30th. Piper Sandler restated a “neutral” rating and set a $254.00 price objective (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Truist Financial upped their target price on shares of Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Finally, Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $327.17.

Humana Stock Performance

Shares of NYSE HUM opened at $388.09 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market cap of $46.59 billion, a P/E ratio of 41.51, a P/E/G ratio of 2.07 and a beta of 0.71. The firm’s fifty day moving average is $367.16 and its two-hundred day moving average is $266.44. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the previous year, the company earned $11.58 EPS. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. As a group, analysts anticipate that Humana Inc. will post 9.46 EPS for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.